From: Changes in practice patterns affecting in-hospital and post-discharge survival among ACS patients
Variables: | Hazard Ratios | 95% CI | p-value | Δχ2-value |
---|---|---|---|---|
Age | 1.03 | 1.01–1.04 | <0.01 | 15.79 |
Gender (male)* | 1.14 | 0.82–1.59 | >0.45 | 0.57 |
Race (white)* | 0.81 | 0.54–1.23 | >0.32 | 0.98 |
Charlson Index*** | 1.81 | 1.33–2.46 | <0.01 | 14.45 |
Ejection Fraction (<35%)* | Â | Â | Â | 6.78** |
   35%–44% | 1.59 | 0.89–2.83 | >0.11 | 2.49 |
   ≥45% | 0.56 | 0.31–1.01 | >0.05 | 3.71 |
   missing | 1.19 | 0.68–2.07 | >0.54 | 0.37 |
Invasive Procedures (none)* | Â | Â | Â | 19.58** |
   CATH | 0.56 | 0.34–0.91 | <0.02 | 5.45 |
   PCI | 0.29 | 0.16–0.53 | <0.01 | 15.75 |
   CABG | 0.39 | 0.22–0.67 | <0.01 | 11.24 |
ACEIs & ARBs – discharge | 1.06 | 0.75–1.48 | >0.75 | 0.10 |
Beta Blockers – discharge | 0.54 | 0.36–0.81 | <0.01 | 8.78 |
Aspirin – discharge | 0.79 | 0.56–1.10 | >0.15 | 1.99 |
Time Cohorts (MICH1)* | Â | Â | Â | 1.67** |
   MICH2 | 1.29 | 0.87–1.92 | >0.21 | 1.56 |
   HARP | 1.19 | 0.77–1.85 | >0.43 | 0.62 |